These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19307116)

  • 21. 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.
    Skinner PJ; Webb PJ; Sage CR; Dang TH; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4207-9. PubMed ID: 19524438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice.
    Walters RW; Shukla AK; Kovacs JJ; Violin JD; DeWire SM; Lam CM; Chen JR; Muehlbauer MJ; Whalen EJ; Lefkowitz RJ
    J Clin Invest; 2009 May; 119(5):1312-21. PubMed ID: 19349687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
    Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor.
    Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate.
    Shen HC; Ding FX; Raghavan S; Deng Q; Luell S; Forrest MJ; Carballo-Jane E; Wilsie LC; Krsmanovic ML; Taggart AK; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2010 Mar; 53(6):2666-70. PubMed ID: 20184326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.
    Peters JU; Kühne H; Dehmlow H; Grether U; Conte A; Hainzl D; Hertel C; Kratochwil NA; Otteneder M; Narquizian R; Panousis CG; Ricklin F; Röver S
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5426-30. PubMed ID: 20724150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
    Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
    J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
    Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
    J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
    Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
    Boatman PD; Lauring B; Schrader TO; Kasem M; Johnson BR; Skinner P; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Luo WL; Caro L; Cote J; Lai E; Wagner J; Taggart AK; Carballo-Jane E; Hammond M; Colletti SL; Tata JR; Connolly DT; Waters MG; Richman JG
    J Med Chem; 2012 Apr; 55(8):3644-66. PubMed ID: 22435740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
    Tang H; Lu JY; Zheng X; Yang Y; Reagan JD
    Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel treatment target for Parkinson's disease.
    Wakade C; Chong R
    J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A.
    Miyazawa Y; Yamaguchi T; Yamaguchi M; Tago K; Tamura A; Sugiyama D; Aburatani T; Nishizawa T; Kurikawa N; Kono K
    Bioorg Med Chem Lett; 2020 May; 30(10):127105. PubMed ID: 32199732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpressing cell systems are a competitive option to primary adipocytes when predicting in vivo potency of dual GPR81/GPR109A agonists.
    Almquist J; Hovdal D; Ahlström C; Fjellström O; Gennemark P; Sundqvist M
    Eur J Pharm Sci; 2018 Mar; 114():155-165. PubMed ID: 29180298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.
    Sasmal PK; Reddy DS; Talwar R; Venkatesham B; Balasubrahmanyam D; Kannan M; Srinivas P; Kyasa SK; Devi BN; Jadhav VP; Khan SK; Mohan P; Chaudhury H; Bhuniya D; Iqbal J; Chakrabarti R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):562-8. PubMed ID: 21075633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinic acid receptor subtypes and their ligands.
    Soudijn W; van Wijngaarden I; Ijzerman AP
    Med Res Rev; 2007 May; 27(3):417-33. PubMed ID: 17238156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
    Hanson J; Gille A; Zwykiel S; Lukasova M; Clausen BE; Ahmed K; Tunaru S; Wirth A; Offermanns S
    J Clin Invest; 2010 Aug; 120(8):2910-9. PubMed ID: 20664170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
    J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.